RadioMedix Debuts Proprietary bench top 212Pb Generator to Support Targeted Alpha Therapy Development
New bench top²¹²Pb generator to expand clinical-grade isotope supply for targeted alpha therapy research and development HOUSTON, June 12, 2025– RadioMedix, Inc., a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and cancer therapy, today announced the launch of RAHA-100, its proprietary, bench top generator technology designed to streamline the production of […]
